TAKEDA PHARMA A/S — Credit Rating and Financial Key Figures

TAKEDA PHARMA A/S (CVR number: 16406899) is a company from VALLENSBÆK. The company reported a net sales of 1118.7 mDKK in 2023, demonstrating a growth of 5.4 % compared to the previous year. The operating profit percentage was at 30.2 % (EBIT: 337.6 mDKK), while net earnings were 261.2 mDKK. The profitability of the company measured by Return on Assets (ROA) was 63.5 %, which can be considered excellent and Return on Equity (ROE) was 115.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 61.1 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. TAKEDA PHARMA A/S's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.